Hindustan Copper Limited reports the death of a contractual employee at the Malanjkhand Copper Project in Balaghat District, Madhya Pradesh, on November 19, 2025. The employee, engaged by a mining contractor, died due to an accident. The company has expressed its condolences for this unfortunate incident.

Accident at Malanjkhand Copper Project

On November 19, 2025, an unfortunate accident occurred at the Malanjkhand Copper Project in the Balaghat District of Madhya Pradesh, resulting in the death of a contractual employee.

Details of the Incident

The employee, who was engaged by a mining contractor working at the Balaghat Copper Project, tragically lost their life in an accident. Hindustan Copper Limited has expressed deep sorrow over the incident and mourns the loss of life.

Source: BSE

Data Patterns (India) Limited announced strong financial results for Q2 and H1 FY26. Revenue more than doubled in H1, reaching INR407 crores. The company’s order book stands at approximately INR1,300 crores, including negotiated orders pending receipt. Despite margin pressure from a strategic project, EBITDA and PAT remained healthy at INR100 crores and INR75 crores, respectively. The company anticipates continued growth and high-value orders in the coming quarters.

Financial Performance Highlights

Data Patterns reported a substantial increase in revenue for both the second quarter and the first half of fiscal year 2026. Key highlights include:

• Q2 FY26 Revenue: Increased to INR308 crores, a 238% year-over-year increase.
• H1 FY26 Revenue: Reached INR407 crores, reflecting a 109% year-over-year growth.
• H1 EBITDA: Stood at INR101 crores.
• H1 Net Profit: Recorded at INR75 crores, an 18% increase year-over-year.

Order Book and Inflows

The company’s order book remains robust, driven by significant orders from key clients:

• Total Order Book: Approximately INR1,300 crores.
• Fresh Order Inflows (H1): INR351 crores, including significant contributions from BrahMos and ECIL.

Strategic Initiatives and Outlook

Data Patterns is focused on several strategic initiatives to drive future growth:

• Secured EW orders developed from QIP funds and utilized approximately INR122 crores from QIP proceeds for product development.
• Export order book remains healthy at around INR80 crores.
• Company transitioning to full systems integrator, designing complete radar and EW systems in-house.
• Confident of achieving earlier guidance on revenue and margins with a healthy order pipeline.

Strategic Project Impact

Margins were temporarily impacted due to the execution of a strategic project amounting to INR180 crores during Q2, taken at a competitive price for long-term opportunities. However, core profitability remains healthy and margins are expected to improve in the second half of the fiscal year.

Source: BSE

Samvardhana Motherson International Limited has announced that its Board of Directors approved a revised Code of Conduct for the prevention of insider trading. This decision was made at a board meeting held on November 13, 2025. The updated code aims to ensure fair practices and transparency in handling unpublished price-sensitive information within the company. Details of the revised code are available on the company’s website.

Revised Code Approved

The Board of Directors of Samvardhana Motherson International Limited convened on November 13, 2025, and approved the revised ‘Code of Conduct for Prevention of Insider Trading and Fair Disclosure of Unpublished Price Sensitive Information’.

Accessing the Code

The full details of the approved Code of Conduct are readily available on the company’s website at www.motherson.com. Stakeholders can visit the website to review the complete document.

Source: BSE

Kirloskar Brothers has updated the stock exchanges regarding a notice received under the Andhra Pradesh GST Act, 2017, related to alleged tax arrears. The notice pertains to arrears of Rs. 15,48,02,928/- for the year 2017-18. The company has filed a Writ Petition challenging the demand, and the High Court has granted an interim stay against recovery proceedings.

Background of the APGST Notice

Kirloskar Brothers Limited (KBL) is providing an update concerning a notice received under the Andhra Pradesh GST (APGST) Act, 2017. This relates to alleged tax arrears associated with a transaction undertaken by an unincorporated Joint Venture (JV) named IVRCL-KBL-MEIL (JV) Hyderabad. The JV includes IVRCL Ltd., Kirloskar Brothers, and Megha Engineering & Infrastructure Ltd. (MEIL) and was formed for a project with the Water Resources Department of the Government of Andhra Pradesh.

Details of the Demand

The demand notice, dated August 5, 2025, from the Assistant Commissioner (ST), Dwarakanagar Circle, Vishakhapatnam, claims tax arrears of Rs. 15,48,02,928/- for the year 2017-18. This demand was to be paid within 7 days of the notice’s receipt. Earlier notices, dated January 21, 2025, issued to the majority of the Company’s Directors, erroneously mentioned arrears of Rs. 15,48,06,528/- for the year 2023-24.

Legal Action and Current Status

To address this demand, Kirloskar Brothers filed a Writ Petition on August 12, 2025 (WP/31611/2025), challenging the demand notice with a prayer to set aside the assessment order. The Hon’ble High Court for the State of Andhra Pradesh at Amaravati has granted an interim stay against the recovery proceedings via an order dated August 20, 2025, which was made available to the Company on August 26, 2025. Furthermore, the Directors who received the original demand notices also filed Writ Petitions, under filing No. WP/47631/2025 dated 19.11.2025, challenging the Demand Notices with a prayer to set aside the impugned assessment order.

Opposing Parties in the Litigation

The opposing parties in this litigation are:

1. The Deputy Assistant Commissioner of State Tax, Dwarakanagar Circle, Visakhapatnam-l Division.
2. The GST Officer, Dwarakanagar Circle, Visakhapatnam-I Division.
3. The State of Andhra Pradesh, represented by its Principal Secretary, Revenue Department, Commercial Taxes.

Source: BSE

Shriram Finance has confirmed the dematerialization of security certificates as per regulations. Integrated Registry Management Services Private Limited, the registrar, verified and cancelled the physical certificates, substituting them with depository records. This process, completed by November 19, 2025, ensures all securities are listed on the stock exchanges and the depository is registered as the owner.

Security Certificate Update

Shriram Finance confirms the listing of securities comprised in the certificates on the Stock Exchanges. Our Registrar and Share Transfer Agent, Integrated Registry Management Services Private Limited, has verified, mutilated, and cancelled certificates of security received for dematerialization.

Dematerialization Confirmation

The name of the depository has been substituted in the register of members as the registered owner. This confirmation is based on the report and certificate dated November 19, 2025, received from our R & T Agent.

Details of Share Certificates Dematerialized

Details of share certificates dematerialized from 01/11/2025 to 15/11/2025:

Source: BSE

Life Insurance Corporation of India (LIC) will be participating in an Analyst/Institutional Investor Meet on November 19, 2025. The meeting, a JM Financial Flagship India Conference, will take place in Mumbai at The St. Regis. This is to inform investors that representatives from LIC have participated in the following Investors’ Meet, where no unpublished price sensitive information was shared/discussed.

Analyst/Institutional Investor Conference

LIC representatives participated in an Analyst/Institutional Investor Meet on November 19, 2025 in Mumbai.

Meeting Details

The event was the JM Financial Flagship India Conference, held at The St. Regis, Mumbai. The format was Group and one on one meetings.

Disclosure

During the Investors’ Meet, no unpublished price-sensitive information was shared or discussed.

Source: BSE

Max Healthcare Institute Limited presented an investor presentation on November 19, 2025, detailing the company’s strategic initiatives, financial highlights, and future growth drivers. The presentation highlighted Max Healthcare’s position as India’s largest hospital chain in terms of market capitalization and its commitment to clinical excellence. Key strategies include optimizing infrastructure, expanding bed capacity, and leveraging technology to drive industry-leading ROCEs.

Strategic Growth Initiatives

Max Healthcare aims to strengthen its market position through several key strategies:

• Optimizing Existing Infrastructure: Focus on payor mix, capacity utilization, and process efficiencies.
• Expanding Bed Capacity: Pursuing brownfield and greenfield projects to increase bed count.
• Leveraging Technology: Developing digital ecosystems and deploying advanced medical technologies.
• Mergers & Acquisitions: Seeking strategic acquisitions to enhance market presence.

Financial Highlights

The company reported strong financial performance, with a 24% revenue CAGR over the past four years. H1 FY26 occupancy reached approximately 76%. The company has a relatively low net debt of ₹2,067 Cr as of September 30, 2025, providing headroom for future growth. Max Healthcare’s ROCE was around 28% in H1 FY26, excluding CWIP. This was 38% excluding CWIP for existing units.

Expansion and Bed Capacity

Max Healthcare has plans to expand its capacity by over 8,300 beds, with approximately 4,800 beds expected to be added within the next three to four years through ongoing and planned projects. This expansion includes brownfield and greenfield developments. The company has an available capacity of around 5,200 beds.

Operational Excellence

Key operational highlights include:

• Performing approximately 53,000 cardiac procedures annually.
• Conducting around 14,900 neuro surgeries annually.
• Performing about 44,500 orthopedic surgeries annually.

Source: BSE

NBCC (India) Limited has been awarded a significant project management consultancy (PMC) contract worth approximately ₹2,966.10 Crore by the Nagpur Metropolitan Region Development Authority (NMRDA). The project involves the development of Naveen Nagpur under Phase-1. This new work order aligns with NBCC’s ordinary course of business and bolsters its portfolio.

Significant Project Award

NBCC (India) Limited has secured a substantial project management consultancy (PMC) contract from the Nagpur Metropolitan Region Development Authority (NMRDA). The announcement was made on November 19, 2025.

Project Details

The project entails providing PMC services for the development of Naveen Nagpur under NMRDA Phase-1. The approximate value of this project is ₹2,966.10 Crore (excluding GST).

Contract Terms

The nature of the order is Project Management Consultancy, awarded domestically. The project is aligned with the normal business operations of NBCC (India) Limited.

Source: BSE

Glenmark Pharmaceuticals has uploaded the transcript of its earnings call pertaining to the second quarter (Q2: Jul-Sep) and half-year ended September 30, 2025. The transcript is now available on the company’s website, providing detailed insights into the company’s financial performance and strategic outlook for the periods under review. Stakeholders can access the information for a comprehensive understanding of Glenmark’s recent activities and future plans.

Earnings Call Transcript Available

Glenmark Pharmaceuticals announced that the transcript of the earnings call for the second quarter (Q2: Jul-Sep) and half-year ended September 30, 2025, has been officially uploaded to the company’s website. This provides stakeholders access to detailed discussions and insights into the company’s performance.

Key Reporting Period

The earnings call and subsequent transcript cover Glenmark Pharmaceutical’s financial and operational results for the period ending September 30, 2025. This includes a comprehensive review of the second quarter’s performance and a broader perspective on the first half of the financial year.

Accessing the Transcript

Interested parties can access and download the full transcript from Glenmark Pharmaceuticals’ official website. This resource offers in-depth information about the company’s financial health, strategic initiatives, and future outlook, as discussed during the earnings call held on November 17, 2025.

Source: BSE